Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron
Go back to Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron| Pfizer Inc. (NYSE: PFE) | Delayed: 30.40 -0.12 (0.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.52 | 52 Week High | $37.39 | |||
| Open | $30.45 | 52 Week Low | $28.25 | |||
| Day High | $30.64 | P/E | 18.42 | |||
| Day Low | $30.20 | EPS | $1.65 | |||
| Volume | 12,216,040 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 30.40 -0.12 (0.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.52 | 52 Week High | $37.39 | |||
| Open | $30.45 | 52 Week Low | $28.25 | |||
| Day High | $30.64 | P/E | 18.42 | |||
| Day Low | $30.20 | EPS | $1.65 | |||
| Volume | 12,216,040 | |||||



